Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-14
1997-12-02
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530350, 530399, A61K 3702, A61K 3736, C07G 700
Patent
active
056936141
ABSTRACT:
A subject suffering from ischemic shock is treated by administering to the subject a therapeutically effective amount of aFGF as the active ingredient of a pharmaceutical composition further containing a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4296100 (1981-10-01), Franco
patent: 4378347 (1983-03-01), Franco
patent: 4444760 (1984-04-01), Thomas, Jr.
patent: 4923696 (1990-05-01), Appel
patent: 5057494 (1991-10-01), Sheffield
Research Communications in Psychology, Psychiarty & Behavior, vol. 12, No. 2, 1987, pp. 105-117, H. Laborit, et al., "Phorbol Esters Antagonize Scopolamine-Induced Amnesia of a Passive Avoidance".
Journal De Physiologie, vol. 81, No. 4, 1986, pp. 252-260, D.L. Alkon, et al., "Biochemical Mechanisms of Memory Storage".
Neurobiology of Aging, vol. 11, No. 1, Jan./Feb. 1990, p. 77, J.R. Connor, "Iron Storage and Transport Proteins in the Brain in Aging and Alzheimer's Disease".
Nature, vol. 332, No. 6162, Mar. 24, 1988, pp. 360-361, K.J. Anderson, et al., "Basic Fibroblast Growth Factor Prevents Death of Lesioned Cholinergic Neurons in vivo".
The Merck Index, 11th Edition, 1989, p. 637, Abstract No. 4016, "Fibroblast Growth Factor".
Brain Research, vol. 452, No. 1 & 2, Jun. 14, 1988, pp. 164-174, G. Cole, et al., "Decreased Levels of Protein Kinase C in Alzheimer Brain".
The Canadian Journal of Neurological Sciences, vol. 15, No. 2, May 1988, p. 221, R. Garza, et al., "Influence Des Facteurs Neuronotrophiques Sur La Differenciation Des Neurones Cholinergiques Centraux De Rat En Culture Cellulaire" Translation not supplied.
Illustrated Stedman's Medical Dictionary, 24 Ed. Williams and Wilkins, Baltimore 1982, p. 728.
Walicke, Experimental Neurology, 102, 144-148, 1998.
Esch et al., Biochemical Biophysical Research Communications, 133, No. 2, 554-562, 1985.
Kojima Hiroyuki
Oomura Yutaka
Sasaki Kazuo
Torii Kunio
Ajinomoto Co. Inc.
Schain Howard E.
Touzeao P. Lynn
LandOfFree
Drug for the treatment of senile dementia of the ischemic and hy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug for the treatment of senile dementia of the ischemic and hy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug for the treatment of senile dementia of the ischemic and hy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-801296